Literature DB >> 16273262

The role of serotonin in tumour growth (review).

Emad J Siddiqui1, Cecil S Thompson, Dimitri P Mikhailidis, Faiz H Mumtaz.   

Abstract

Serotonin (5-hydroxytryptamine; 5HT) a monoamine neurotransmitter mediates a wide range of physiological actions in the human body. For example 5HT is implicated in psychiatric and neurological disorders and also plays a fundamental role in tumour growth, differentiation and gene expression. 5HT acts as a growth factor for several types of tumoural and non-tumoural cells. This review considers the role of 5HT and its receptors in the human body with particular reference to carcinogenesis. We conclude that 5HT causes growth proliferation and 5HT antagonists cause growth inhibition in a variety of tumour cells (e.g. prostate carcinoma, lung carcinoma and colonic carcinoma). Therefore, further studies should look into the potential use of 5HT antagonists in the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273262

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  27 in total

1.  Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.

Authors:  Daria Pašalić; Paulina Pauković; Selma Cvijetić; Alica Pizent; Jasna Jurasović; Sanja Milković-Kraus; Slavica Dodig; Dorotea Mück-Šeler; Maja Mustapić; Nela Pivac; Mladen Pavlović
Journal:  Genet Test Mol Biomarkers       Date:  2012-03-15

2.  Altered tryptophan metabolism in human meningioma.

Authors:  Noble Kumar Talari; Manas Panigrahi; Sailaja Madigubba; Sundaram Challa; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2016-07-29       Impact factor: 4.130

Review 3.  Monoamines in glioblastoma: complex biology with therapeutic potential.

Authors:  Seamus Patrick Caragher; Robert Raymond Hall; Riasat Ahsan; Atique U Ahmed
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

4.  Tryptophan metabolism is dysregulated in individuals with Fanconi anemia.

Authors:  Allison L Bartlett; Lindsey Romick-Rosendale; Adam Nelson; Sheyar Abdullah; Nathan Luebbering; Jamen Bartlett; Marion Brusadelli; Joseph S Palumbo; Kelly Lake; Bridget Litts; Alexandra Duell; Annette Urbanski; Adam Lane; Kasiani C Myers; Susanne I Wells; Stella M Davies
Journal:  Blood Adv       Date:  2021-01-12

5.  Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.

Authors:  Yan Xia; Dawei Wang; Nan Zhang; Zhihao Wang; Li Pang
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

6.  Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line.

Authors:  Ramin Ataee; Soheila Ajdary; Mohammadreza Zarrindast; Mehdi Rezayat; Mohammad Reza Hayatbakhsh
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-21       Impact factor: 4.553

7.  Evaluation of neuroendocrine markers in renal cell carcinoma.

Authors:  Hanna Ronkainen; Ylermi Soini; Markku H Vaarala; Saila Kauppila; Pasi Hirvikoski
Journal:  Diagn Pathol       Date:  2010-05-12       Impact factor: 2.644

8.  Serotonin used as prognostic marker of urological tumors.

Authors:  Nina Jungwirth; Lothar Haeberle; Karl Michael Schrott; Bernd Wullich; Frens Steffen Krause
Journal:  World J Urol       Date:  2008-06-26       Impact factor: 4.226

9.  Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line.

Authors:  Toshiaki Shinka; Dai Onodera; Tetsuji Tanaka; Noriaki Shoji; Tadaaki Miyazaki; Tetsuya Moriuchi; Takahiro Fukumoto
Journal:  Oncol Lett       Date:  2011-01-20       Impact factor: 2.967

10.  Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

Authors:  Vaibhav P Pai; Aaron M Marshall; Laura L Hernandez; Arthur R Buckley; Nelson D Horseman
Journal:  Breast Cancer Res       Date:  2009-11-10       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.